The role of various processes (uptake, release, metabolism, and excret
ion) in the hepatic accumulation of dextrans was investigated in isola
ted perfused rat livers (IPRLs). Single-pass IPRLs were infused with f
luorescein-dextran (FD) with a molecular weight (MW) of 70,000 (FD-70)
for 15, 30, 45, or 60 min, and inlet and outlet samples and livers we
re collected. In addition, two groups of livers were infused with FD-7
0 for 60 min, followed by 30 or 60 min of drug-free perfusion. The con
centrations of the macromolecule in the samples were measured by a siz
e exclusion chromatographic method. Similar, but limited, experiments
were also conducted for FDs with MWs of 4,000 (FD-4) and 150,000 (FD-1
50). In addition, the metabolism of all three FDs were investigated us
ing liver homogenates. Because of low hepatic extraction, the concentr
ations of dextrans in the inlet and outlet perfusates were almost the
same during the entire perfusion. However, liver concentrations increa
sed almost linearly during the infusion of FD-70 (0-60 min) and declin
ed slowly thereafter (60-120 min). The apparent hepatic extraction rat
io (E-app) values, estimated directly from the concentrations of FDs i
n the liver, were MW dependent; E-app of FD-4 (0.124% +/- 0.015%) was
significantly (p < 0.05) less than that for FD-70 (0.677% +/- 0.193%)
or FD-150 (0.711% +/- 0.022%). The metabolism and biliary excretion of
all FDs were negligible during the perfusion time. The mean residence
time of FD-70 in the liver, estimated by nonlinear regression analysi
s of experimental data, was 248 min. These studies define the role of
various processes involved in the slow (but substantial) and MW depend
ent hepatic accumulation of dextrans.